Literature DB >> 30054024

Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.

Jae-Hyung Chang1, S Ali Husain2, Dominick Santoriello3, Michael B Stokes3, Clifford D Miles4, Kirk W Foster5, Yifu Li2, Leigh-Anne Dale2, Russell J Crew2, David J Cohen2, Krzysztof Kiryluk2, Ali G Gharavi2, Sumit Mohan6.   

Abstract

The presence of 2 APOL1 risk variants (G1/G1, G1/G2, or G2/G2) is an important predictor of focal segmental glomerulosclerosis (FSGS) and chronic kidney disease in individuals of African descent. Although recipient APOL1 genotype is not associated with allograft survival, kidneys from deceased African American donors with 2 APOL1 risk variants demonstrate shorter graft survival. We present a series of cases of presumed de novo collapsing FSGS in 5 transplanted kidneys from 3 deceased donors later identified as carrying 2 APOL1 risk alleles, including 2 recipients from the same donor whose kidneys were transplanted in 2 different institutions. Four of these recipients had viremia in the period preceding the diagnosis of collapsing FSGS. Cytomegalovirus and BK virus infection were present in 3 and 1 of our 5 cases, respectively, around the time that collapsing FSGS occurred. We discuss viral infections, including active cytomegalovirus infection, as possible "second hits" that may lead to glomerular injury and allograft failure in these recipients. Further studies to identify additional second hits are necessary to better understand the pathologic mechanisms of donor APOL1-associated kidney disease in the recipient.
Copyright © 2018 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apolipoprotein L1 (APOL1); BK virus; allograft failure; case reports; collapsing FSGS; cytomegalovirus (CMV); deceased donor; donor genotype; end-stage renal disease (ESRD); focal segmental glomerulosclerosis (FSGS); genotype; kidney biopsy; kidney transplant outcome; polyomavirus; risk variant; second hit; viral infection; viremia

Mesh:

Substances:

Year:  2018        PMID: 30054024      PMCID: PMC6309648          DOI: 10.1053/j.ajkd.2018.05.008

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  21 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes.

Authors:  David Pérez-Morga; Benoit Vanhollebeke; Françoise Paturiaux-Hanocq; Derek P Nolan; Laurence Lins; Fabrice Homblé; Luc Vanhamme; Patricia Tebabi; Annette Pays; Philippe Poelvoorde; Alain Jacquet; Robert Brasseur; Etienne Pays
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

3.  Severe cyclosporine arteriolopathy with focal segmental glomerulosclerosis is not a fatal finding in chronic renal allograft failure after year 5 of transplantation using cyclosporine.

Authors:  A Takeda; K Morozumi; K Koyama; A Yoshida; K Uchida; Y Tominaga; T Haba; T Oikawa; T Usami; K Sugito; O Takeuchi; T Fujinami; I Yokoyama; H Takagi
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

4.  The APOL1 gene and allograft survival after kidney transplantation.

Authors:  A M Reeves-Daniel; J A DePalma; A J Bleyer; M V Rocco; M Murea; P L Adams; C D Langefeld; D W Bowden; P J Hicks; R J Stratta; J-J Lin; D F Kiger; M D Gautreaux; J Divers; B I Freedman
Journal:  Am J Transplant       Date:  2011-04-12       Impact factor: 8.086

5.  APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease.

Authors:  Derek M Fine; Walter G Wasser; Michelle M Estrella; Mohamed G Atta; Michael Kuperman; Revital Shemer; Arun Rajasekaran; Shay Tzur; Lorraine C Racusen; Karl Skorecki
Journal:  J Am Soc Nephrol       Date:  2011-12-01       Impact factor: 10.121

6.  Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.

Authors:  B I Freedman; B A Julian; S O Pastan; A K Israni; D Schladt; M D Gautreaux; V Hauptfeld; R A Bray; H M Gebel; A D Kirk; R S Gaston; J Rogers; A C Farney; G Orlando; R J Stratta; S Mohan; L Ma; C D Langefeld; P J Hicks; N D Palmer; P L Adams; A Palanisamy; A M Reeves-Daniel; J Divers
Journal:  Am J Transplant       Date:  2015-03-24       Impact factor: 8.086

7.  The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.

Authors:  B T Lee; V Kumar; T A Williams; R Abdi; A Bernhardy; C Dyer; S Conte; G Genovese; M D Ross; D J Friedman; R Gaston; E Milford; M R Pollak; A Chandraker
Journal:  Am J Transplant       Date:  2012-04-04       Impact factor: 8.086

8.  JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.

Authors:  Jasmin Divers; Marina Núñez; Kevin P High; Mariana Murea; Michael V Rocco; Lijun Ma; Donald W Bowden; Pamela J Hicks; Mitzie Spainhour; David A Ornelles; Steven B Kleiboeker; Kara Duncan; Carl D Langefeld; Jolyn Turner; Barry I Freedman
Journal:  Kidney Int       Date:  2013-05-15       Impact factor: 10.612

9.  APOL1 Polymorphisms in a Deceased Donor and Early Presentation of Collapsing Glomerulopathy and Focal Segmental Glomerulosclerosis in Two Recipients.

Authors:  P B Shah; J E Cooper; M S Lucia; C Boils; C P Larsen; A C Wiseman
Journal:  Am J Transplant       Date:  2016-03-29       Impact factor: 8.086

10.  Molecular identification of SV40 infection in human subjects and possible association with kidney disease.

Authors:  Rui-Mei Li; Mary H Branton; Somsak Tanawattanacharoen; Ronald A Falk; J Charles Jennette; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

View more
  16 in total

Review 1.  Common Mechanisms of Viral Injury to the Kidney.

Authors:  Leslie A Bruggeman
Journal:  Adv Chronic Kidney Dis       Date:  2019-05       Impact factor: 3.620

2.  Malaria, Collapsing Glomerulopathy, and Focal and Segmental Glomerulosclerosis.

Authors:  Ariane Amoura; Anissa Moktefi; Matthieu Halfon; Alexandre Karras; Cédric Rafat; Jean-Baptiste Gibier; Patrick J Gleeson; Aude Servais; Nicolas Argy; Pascale Maillé; Xavier Belenfant; Victor Gueutin; Alexia Delpierre; Leila Tricot; Khalil El Karoui; Noémie Jourde-Chiche; Sandrine Houze; Dil Sahali; Vincent Audard
Journal:  Clin J Am Soc Nephrol       Date:  2020-05-22       Impact factor: 8.237

3.  Expanding the spectrum of APOL1-related renal disease: de novo collapsing glomerulopathy following kidney transplant.

Authors:  Jeffrey B Kopp
Journal:  Kidney Int       Date:  2018-12       Impact factor: 10.612

Review 4.  APOL1 Genetic Testing in Living Kidney Transplant Donors.

Authors:  Sumit Mohan; Ana S Iltis; Deirdre Sawinski; James M DuBois
Journal:  Am J Kidney Dis       Date:  2019-04-11       Impact factor: 8.860

Review 5.  Genes and environment in chronic kidney disease hotspots.

Authors:  David J Friedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894

Review 6.  APOL1 Nephropathy: From Genetics to Clinical Applications.

Authors:  David J Friedman; Martin R Pollak
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-02       Impact factor: 8.237

Review 7.  Apolipoprotein L1 and mechanisms of kidney disease susceptibility.

Authors:  Leslie A Bruggeman; John R Sedor; John F O'Toole
Journal:  Curr Opin Nephrol Hypertens       Date:  2021-05-01       Impact factor: 2.894

Review 8.  Kidney disease and APOL1.

Authors:  Aminu Abba Yusuf; Melanie A Govender; Jean-Tristan Brandenburg; Cheryl A Winkler
Journal:  Hum Mol Genet       Date:  2021-04-26       Impact factor: 6.150

9.  Variation of ApoL1 Testing Practices for Living Kidney Donors.

Authors:  Tristan McIntosh; Sumit Mohan; Deirdre Sawinski; Ana Iltis; James M DuBois
Journal:  Prog Transplant       Date:  2019-12-16       Impact factor: 1.187

10.  Apolipoprotein L1: role in the evaluation of kidney transplant donors.

Authors:  Krista L Lentine; Roslyn B Mannon
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-11       Impact factor: 3.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.